> The Iowa attorney general has sued 78 pharmaceutical companies, alleging that they inflated their prices for Medicaid patients, costing the state millions over several years. With this effort, Iowa joins more than 20 states who have sued drug makers over alleged overpayments. Report
> Jurors are deliberating in Reno, Nevada, today in product liability trial over the Wyeth Pharmaceuticals drugs Premarin and Prempro. Three women with breast cancer allege that the hormone replacements caused their disease. Report
> A Johnson & Johnson unit has filed a patent-infringement suit against Hologic Inc. At issue are four patents on a breast tumor-detection system. Report
> Merck KgaA has named a new manager for its liquid crystals division, Walter Galinat. Galinat, who had run the company's performance and life science chemicals unit, will replace Dr. Paul Breddels. Report
> China's willingness to get aggressive in protecting biopharma's intellectual property is being credited with its surge past India in the total number of completed and ongoing clinical trials. Report
> Canada's QLT has snapped up new drug delivery technology for eye conditions with its $42 million acquisition of ForSight Newco II. Report
And Finally... A recent conference in Philadelphia included some bold projections for biotech as the industry approaches the $100 billion mark for collective revenue. Report